BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 12604709)

  • 1. The nitric oxide- and prostaglandin-independent component of the renal vasodilator effect of thimerosal is mediated by epoxyeicosatrienoic acids.
    Chen YJ; Jiang H; Quilley J
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1292-8. PubMed ID: 12604709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the rat heart.
    Fulton D; Mcgiff JC; Quilley J
    J Pharmacol Exp Ther; 1998 Nov; 287(2):497-503. PubMed ID: 9808672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin.
    Imig JD; Falck JR; Wei S; Capdevila JH
    J Vasc Res; 2001; 38(3):247-55. PubMed ID: 11399897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5,6-epoxyeicosatrienoic acid mediates the enhanced renal vasodilation to arachidonic acid in the SHR.
    Pomposiello SI; Quilley J; Carroll MA; Falck JR; McGiff JC
    Hypertension; 2003 Oct; 42(4):548-54. PubMed ID: 12939232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of nitric oxide, EDHF, and EETs to endothelium-dependent relaxation in renal afferent arterioles.
    Wang D; Borrego-Conde LJ; Falck JR; Sharma KK; Wilcox CS; Umans JG
    Kidney Int; 2003 Jun; 63(6):2187-93. PubMed ID: 12753306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins.
    Carroll MA; Balazy M; Margiotta P; Falck JR; McGiff JC
    J Biol Chem; 1993 Jun; 268(17):12260-6. PubMed ID: 8509363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels.
    Archer SL; Gragasin FS; Wu X; Wang S; McMurtry S; Kim DH; Platonov M; Koshal A; Hashimoto K; Campbell WB; Falck JR; Michelakis ED
    Circulation; 2003 Feb; 107(5):769-76. PubMed ID: 12578883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of NO-cGMP pathway and potassium channels on the relaxation induced by clonidine in the rat mesenteric arterial bed.
    Pimentel AM; Costa CA; Carvalho LC; Brandão RM; Rangel BM; Tano T; Soares de Moura R; Resende AC
    Vascul Pharmacol; 2007 May; 46(5):353-9. PubMed ID: 17258511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K(+)-induced vasodilation in the rat kidney is dependent on the endothelium and activation of K+ channels.
    Quilley J; Qiu Y
    Eur J Pharmacol; 2005 Jan; 508(1-3):193-9. PubMed ID: 15680271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of epoxyeicosatrienoic acids in renal functional response to inhibition of NO production in the rat.
    Ogungbade GO; Akinsanmi LA; Jiang H; Oyekan AO
    Am J Physiol Renal Physiol; 2003 Nov; 285(5):F955-64. PubMed ID: 12865253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat.
    Fulton D; Quilley J
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1146-51. PubMed ID: 9732371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide-epoxygenase interactions and arachidonate-induced dilation of rat renal microvessels.
    Udosen IT; Jiang H; Hercule HC; Oyekan AO
    Am J Physiol Heart Circ Physiol; 2003 Nov; 285(5):H2054-63. PubMed ID: 12881223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole.
    Arima S; Endo Y; Yaoita H; Omata K; Ogawa S; Tsunoda K; Abe M; Takeuchi K; Abe K; Ito S
    J Clin Invest; 1997 Dec; 100(11):2816-23. PubMed ID: 9389747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence against a cytochrome P450-derived reactive oxygen species as the mediator of the nitric oxide-independent vasodilator effect of bradykinin in the perfused heart of the rat.
    Fulton D; McGiff JC; Wolin MS; Kaminski P; Quilley J
    J Pharmacol Exp Ther; 1997 Feb; 280(2):702-9. PubMed ID: 9023282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms.
    Lu T; Ye D; Wang X; Seubert JM; Graves JP; Bradbury JA; Zeldin DC; Lee HC
    J Physiol; 2006 Sep; 575(Pt 2):627-44. PubMed ID: 16793897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal characteristics of nitric oxide-, prostaglandin-, and EDHF-mediated components of endothelium-dependent vasodilation in the kidney.
    Dautzenberg M; Just A
    Am J Physiol Regul Integr Comp Physiol; 2013 Nov; 305(9):R987-98. PubMed ID: 23986361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.
    El-Mas MM; Mohy El-Din MM; El-Gowilly SM; Sharabi FM
    Eur J Pharmacol; 2004 Mar; 487(1-3):149-58. PubMed ID: 15033387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The position of NO among endogenous vasodilators.
    Quilley J; Fulton D; McGiff JC
    Pol J Pharmacol; 1994; 46(6):523-30. PubMed ID: 7620514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of nitric oxide and potassium channels in the bradykinin-induced vasodilatation in the rat kidney perfused ex situ.
    Pompermayer K; Assreuy J; Vieira MA
    Regul Pept; 2002 May; 105(3):155-62. PubMed ID: 11959369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence against a role of cytochrome P450-derived arachidonic acid metabolites in endothelium-dependent hyperpolarization by acetylcholine in rat isolated mesenteric artery.
    Fukao M; Hattori Y; Kanno M; Sakuma I; Kitabatake A
    Br J Pharmacol; 1997 Feb; 120(3):439-46. PubMed ID: 9031747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.